BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1875197)

  • 21. Localization of a neutralizing epitope on the envelope protein of dengue virus type 2.
    Lin B; Parrish CR; Murray JM; Wright PJ
    Virology; 1994 Aug; 202(2):885-90. PubMed ID: 7518164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products.
    Clegg JC; Wilson SM; Oram JD
    Virus Res; 1991 Mar; 18(2-3):151-64. PubMed ID: 2042397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein.
    Balasuriya UB; Patton JF; Rossitto PV; Timoney PJ; McCollum WH; MacLachlan NJ
    Virology; 1997 May; 232(1):114-28. PubMed ID: 9185595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Whitewater Arroyo virus: natural evidence for genetic recombination among Tacaribe serocomplex viruses (family Arenaviridae).
    Charrel RN; de Lamballerie X; Fulhorst CF
    Virology; 2001 May; 283(2):161-6. PubMed ID: 11336541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping the neutralizing epitopes on the glycoprotein of infectious haematopoietic necrosis virus, a fish rhabdovirus.
    Huang C; Chien MS; Landolt M; Batts W; Winton J
    J Gen Virol; 1996 Dec; 77 ( Pt 12)():3033-40. PubMed ID: 9000094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single amino acid change within antigenic domain II of the spike protein of bovine coronavirus confers resistance to virus neutralization.
    Yoo D; Deregt D
    Clin Diagn Lab Immunol; 2001 Mar; 8(2):297-302. PubMed ID: 11238212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allpahuayo virus: a newly recognized arenavirus (arenaviridae) from arboreal rice rats (oecomys bicolor and oecomys paricola) in northeastern peru.
    Moncayo AC; Hice CL; Watts DM; Travassos de Rosa AP; Guzman H; Russell KL; Calampa C; Gozalo A; Popov VL; Weaver SC; Tesh RB
    Virology; 2001 Jun; 284(2):277-86. PubMed ID: 11384226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fine mapping of virus-neutralizing epitopes on hepatitis B virus PreS1.
    Maeng CY; Ryu CJ; Gripon P; Guguen-Guillouzo C; Hong HJ
    Virology; 2000 Apr; 270(1):9-16. PubMed ID: 10772975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies.
    Balasuriya UB; Rossitto PV; DeMaula CD; MacLachlan NJ
    J Gen Virol; 1993 Nov; 74 ( Pt 11)():2525-9. PubMed ID: 7504076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
    Chen Z; Li K; Plagemann PG
    Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The amino-terminal residue of glycoprotein B is critical for neutralization of bovine herpesvirus 1.
    Okazaki K; Fujii S; Takada A; Kida H
    Virus Res; 2006 Feb; 115(2):105-11. PubMed ID: 16153736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigenic variation of SIV: mutations in V4 alter the neutralization profile.
    Kinsey NE; Anderson MG; Unangst TJ; Joag SV; Narayan O; Zink MC; Clements JE
    Virology; 1996 Jul; 221(1):14-21. PubMed ID: 8661410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single amino acid substitutions in Puumala virus envelope glycoproteins G1 and G2 eliminate important neutralization epitopes.
    Hörling J; Lundkvist A
    Virus Res; 1997 Apr; 48(1):89-100. PubMed ID: 9140197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence.
    Jiang WR; Lowe A; Higgs S; Reid H; Gould EA
    J Gen Virol; 1993 May; 74 ( Pt 5)():931-5. PubMed ID: 8388021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid sequence evolution of street rabies glycoprotein is related to the highly heterogeneous nature of the viral population.
    Benmansour A; Brahimi M; Tuffereau C; Coulon P; Lafay F; Flamand A
    Virology; 1992 Mar; 187(1):33-45. PubMed ID: 1736537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization.
    Minson AC; Hodgman TC; Digard P; Hancock DC; Bell SE; Buckmaster EA
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1001-13. PubMed ID: 2423636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural and functional studies on a unique linear neutralizing antigenic site (G5) of the rabies virus glycoprotein.
    van der Heijden RW; Langedijk JP; Groen J; UytdeHaag FG; Meloen RH; Osterhaus AD
    J Gen Virol; 1993 Aug; 74 ( Pt 8)():1539-45. PubMed ID: 7688410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic characterization and phylogeny of Sabiá virus, an emergent pathogen in Brazil.
    Gonzalez JP; Bowen MD; Nichol ST; Rico-Hesse R
    Virology; 1996 Jul; 221(2):318-24. PubMed ID: 8661442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA.
    Auperin DD; Sasso DR; McCormick JB
    Virology; 1986 Oct; 154(1):155-67. PubMed ID: 3750844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.